Belumosudil Mesylate
Brand name: Rezurock
Rank #244 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$52.3M
Total Cost
2,280
Total Claims
$52.3M
Total Cost
89
Prescribers
$23K
Cost per Claim
71
Beneficiaries
2,303
30-Day Fills
$587K
Avg Cost/Provider
26
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$52.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $52.3M total
🔎 Data Overview
At $22,932 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $587,484 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $736,423 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Belumosudil Mesylate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Ellen Baldino | Physician Assistant | Charleston, SC | 115 | $2.9M |
| 2 | Alfredo Axtmayer | Nurse Practitioner | New Haven, CT | 125 | $2.8M |
| 3 | Doris Ponce | Hematology-Oncology | New York, NY | 96 | $2.2M |
| 4 | Michele Donato | Medical Oncology | Hackensack, NJ | 92 | $1.9M |
| 5 | Sam Penza | Undefined Physician type | Columbus, OH | 61 | $1.6M |
| 6 | Linda Perry | Physician Assistant | Philadelphia, PA | 53 | $1.3M |
| 7 | Vincent Ho | Hematology-Oncology | Boston, MA | 54 | $1.2M |
| 8 | Amelia Langston | Medical Oncology | Atlanta, GA | 52 | $1.2M |
| 9 | Chelsea Veranis | Physician Assistant | Charleston, SC | 38 | $1.1M |
| 10 | Kristin Geary | Nurse Practitioner | Seattle, WA | 45 | $1.1M |
| 11 | Joseph Pidala | Medical Oncology | Tampa, FL | 41 | $1.1M |
| 12 | Danielle Murphy | Nurse Practitioner | Nashville, TN | 39 | $1.1M |
| 13 | Robert Byram | Nurse Practitioner | New Orleans, LA | 47 | $849K |
| 14 | Stephanie Myszka | Nurse Practitioner | Buffalo, NY | 37 | $844K |
| 15 | Stephanie Tsai | Internal Medicine | Maywood, IL | 33 | $830K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 241 | Buspirone Hcl (Buspirone Hcl) | $53.7M | 2,868,147 |
| 242 | Oxybutynin Chloride (Oxybutynin Chloride Er) | $53.4M | 1,872,901 |
| 243 | Raltegravir Potassium (Isentress) | $53.0M | 25,491 |
| 244 | Belumosudil Mesylate (Rezurock) | $52.3M | 2,280 |
| 245 | Pegloticase (Krystexxa) | $52.2M | 1,134 |
| 246 | Estrogens, Conjugated (Premarin) | $52.0M | 130,171 |
| 247 | Ranolazine (Ranolazine Er) | $51.6M | 381,631 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology